KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $3.1 billion.

  • Incyte's Cash & Equivalents rose 8353.86% to $3.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.1 billion, marking a year-over-year increase of 8353.86%. This contributed to the annual value of $3.1 billion for FY2025, which is 8353.86% up from last year.
  • Incyte's Cash & Equivalents amounted to $3.1 billion in Q4 2025, which was up 8353.86% from $2.5 billion recorded in Q3 2025.
  • Incyte's 5-year Cash & Equivalents high stood at $3.3 billion for Q1 2024, and its period low was $987.3 million during Q2 2024.
  • For the 5-year period, Incyte's Cash & Equivalents averaged around $2.4 billion, with its median value being $2.3 billion (2022).
  • In the last 5 years, Incyte's Cash & Equivalents crashed by 6846.84% in 2024 and then soared by 9801.31% in 2025.
  • Incyte's Cash & Equivalents (Quarter) stood at $2.1 billion in 2021, then skyrocketed by 43.45% to $3.0 billion in 2022, then grew by 8.88% to $3.2 billion in 2023, then plummeted by 47.47% to $1.7 billion in 2024, then skyrocketed by 83.54% to $3.1 billion in 2025.
  • Its Cash & Equivalents stands at $3.1 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.0 billion for Q2 2025.